Abiomed, Inc. ABMD
381.02 0.00 (+0.00%)
At closeDec 21, 2022, 4:00 PM EST
380.55 Day range 381.28
52-week range unavailable
- Market cap
- 17.18B
- Forward P/E
- 60.77
- Volume
- 15.70M
- Open
- 380.78
- Previous close
- 381.02
- Day's range
- 380.55 – 381.28
- Analysts
- Hold
- Earnings date
- Feb 2, 2023
2Y +19.31 (+5.34%)
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 351.42
- 200-day average
- 291.67
Analyst view
Consensus: hold
Hold
Price target (mean) —
Ratings (0m) 10 8 buy · 2 hold · 0 sell
- Strong buy5
- Buy3
- Hold2
- Sell0
- Strong sell0
Next earnings
Feb 2, 2023
Expected Feb 2, 2023. Consensus EPS estimate 0.00.
Financials — quick view
ABMD Revenue — quarterly 265.92M
ABMD Net income — quarterly 106.13M
ABMD EPS — quarterly 2.34
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 2, 2023 | Dec 1, 2022 | 1.03 | — | — | — |
| Nov 1, 2022 | Sep 1, 2022 | 1.05 | — | — | — |
| Aug 4, 2022 | Jun 1, 2022 | 1.08 | — | — | — |
| Apr 28, 2022 | Mar 1, 2022 | 1.08 | — | — | — |
| Feb 3, 2022 | Dec 1, 2021 | 0.98 | — | — | — |
| Oct 28, 2021 | Sep 1, 2021 | 0.98 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 1, 2022 | Morgan Stanley | up | Underweight | Equal-Weight |
| Nov 1, 2022 | Deutsche Bank | down | Buy | Hold |
| Oct 31, 2022 | William Blair | down | Outperform | Market Perform |
| Oct 31, 2022 | Piper Sandler | down | Overweight | Neutral |
| Oct 12, 2022 | Mizuho | init | — | Buy |
| Oct 9, 2022 | Piper Sandler | main | — | Overweight |
News
Getinge's subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S. 
IoMT Wearable Devices Patent Landscape Report and Forecasts, 2017-2023 & 2024-2032 Featuring Veniam, Advanced Neuromodulation Systems, Bionet Sonar, and Abiomed 
US FDA classifies recall of Abiomed's blood pumps as most serious 
3 Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio 
FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial 
Warren Buffett Loves These Stocks. Should You Buy Them Before 2023? 
Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022 
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, OPNT, BNFT, ABMD 
First Patients in the World Treated with Impella RP Flex with SmartAssist 
Eleven Stocks Turned $10,000 To $261,421 In 11 Months
Your note
Sign in to keep a note on ABMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEGAN MARC A. | General Counsel | Sale | Nov 3, 2022 | 12,237 |
| GREENFIELD ANDREW J | Officer | Stock Award(Grant) | Dec 15, 2022 | 15,977 |
| MINOGUE MICHAEL R | Chief Executive Officer | Stock Award(Grant) | Dec 15, 2022 | 380,048 |
| PLANO MATTHEW T | Officer | Sale | Oct 31, 2022 | 10,270 |
| RIVET JEANNINE M. | Director | Stock Award(Grant) | Aug 9, 2022 | 9,966 |
| ROSE ERIC A | Director | Stock Award(Grant) | Aug 9, 2022 | 15,203 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group, Inc. (The) | 11.69% | 5,269,340 | 1.29B | Sep 29, 2022 |
| Blackrock Inc. | 10.11% | 4,560,483 | 1.12B | Sep 29, 2022 |
| Baillie Gifford and Company | 8.04% | 3,624,937 | 890.50M | Sep 29, 2022 |
| State Street Corporation | 4.59% | 2,071,180 | 508.81M | Sep 29, 2022 |
| Primecap Management Company | 3.34% | 1,506,272 | 370.03M | Sep 29, 2022 |
| Wellington Management Group, LLP | 3.22% | 1,453,669 | 357.11M | Sep 29, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.00% | 1,354,236 | 332.68M | Sep 29, 2022 |
| Vanguard U.S. Growth Fund | 2.70% | 1,216,666 | 315.46M | Aug 30, 2022 |
| Vanguard Mid-Cap Index Fund | 2.33% | 1,049,159 | 257.74M | Sep 29, 2022 |
| Vanguard 500 Index Fund | 2.29% | 1,030,404 | 253.13M | Sep 29, 2022 |
| Mainstay Winslow Large Cap Growth Fund | 1.71% | 769,500 | 225.47M | Jul 30, 2022 |
| Primecap Odyssey Aggressive Growth Fund | 1.68% | 758,623 | 186.36M | Sep 29, 2022 |